These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8145103)

  • 1. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis.
    Abdullah AM; Scott RB; Martin SR
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):441-4. PubMed ID: 8145103
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute pancreatitis during oral 5-aminosalicylic acid therapy.
    Fiorentini MT; Fracchia M; Galatola G; Barlotta A; de la Pierre M
    Dig Dis Sci; 1990 Sep; 35(9):1180-2. PubMed ID: 2390934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pancreatitis in a child with idiopathic ulcerative colitis on long-term 5-aminosalicylic acid therapy.
    Paul AC; Oommen SP; Angami S; Moses PD
    Indian J Gastroenterol; 2000; 19(4):195-6. PubMed ID: 11059196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatitis associated with 5-aminosalicylic acid].
    Eckardt VF; Kanzler G; Rieder H; Ewe K
    Dtsch Med Wochenschr; 1991 Apr; 116(14):540-2. PubMed ID: 1707359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis.
    Garau P; Orenstein SR; Neigut DA; Kocoshis SA
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):481-5. PubMed ID: 7520936
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatitis after rectal administration of 5-aminosalicylic acid.
    Isaacs KL; Murphy D
    J Clin Gastroenterol; 1990 Apr; 12(2):198-9. PubMed ID: 1969872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of mesalamine and olsalazine in ulcerative colitis.
    Gait JE; Powell JH; Regalli G
    Am Fam Physician; 1993 Nov; 48(7):1234, 1236. PubMed ID: 8237737
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].
    Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M
    Therapie; 1999; 54(1):41-8. PubMed ID: 10216421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
    Niv Y
    Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
    [No Abstract]   [Full Text] [Related]  

  • 10. Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.
    Austin CA; Cann PA; Jones TH; Holdsworth CD
    Lancet; 1984 Apr; 1(8382):917-8. PubMed ID: 6143230
    [No Abstract]   [Full Text] [Related]  

  • 11. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
    Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.
    Adachi E; Okazaki K; Matsushima Y; Seno H; Uchida K; Nakase H; Kawanami C; Nakamura T; Chiba T
    Int J Pancreatol; 1999 Jun; 25(3):217-21. PubMed ID: 10453423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pancreatitis secondary to long-term 5- aminosalicylic acid therapy in a patient with ulcerative colitis: a case-report.
    Ouakaa-Kchaou A; Gargouri D; Kochlef A; Bibani N; Elloumi H; Trad D; Kharrat J
    Tunis Med; 2014 Jun; 92(6):423. PubMed ID: 25741849
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute interstitial nephritis caused by 5-aminosalicylic acid?].
    Ruf-Ballauf W; Hofstädter F; Krentz K
    Internist (Berl); 1989 Apr; 30(4):262-4. PubMed ID: 2661466
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858
    [No Abstract]   [Full Text] [Related]  

  • 16. New salicylates as maintenance treatment in ulcerative colitis.
    Sninsky CA
    Gut; 1995 Apr; 36(4):640. PubMed ID: 7737578
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung disease associated with orally administered mesalamine for ulcerative colitis.
    Reinoso MA; Schroeder KW; Pisani RJ
    Chest; 1992 May; 101(5):1469-71. PubMed ID: 1582327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug management of ulcerative colitis.
    Barrow S; Rees SH
    BMJ; 1992 Oct; 305(6857):832. PubMed ID: 1422379
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mesalazine (5-ASA) in ulcerative colitis].
    Dybdahl JH
    Tidsskr Nor Laegeforen; 1990 Oct; 110(24):3130-1. PubMed ID: 2237871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.